The carcinogenicity debate on formaldehyde: How to derive safe exposure limits?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Systematic evaluation of PAXgene® tissue fixation for the histopathological and molecular study of lung cancer.The journal of pathology. Clinical research · 2020
   Article
2. Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres.Toxicology research · 2016
   Article
3. Comparison of histomorphology and DNA preservation produced by fixatives in the veterinary diagnostic laboratory setting.PeerJ · 2014
   Article
4. New results on formaldehyde: the 2nd International Formaldehyde Science Conference (Madrid, 19-20 April 2012).Archives of toxicology · 2013
   Article
5. Histological assessment of PAXgene tissue fixation and stabilization reagents.PloS one · 2011
   Article

Corrections and comments

• Comment on
  Cancer effects of formaldehyde: a proposal for an indoor air guideline value.2010

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as